Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Intern Med. 2009 Oct 20;151(8):JC4-8.

ACP Journal Club. Rosiglitazone was noninferior to metformin plus sulfonylurea for CV events but increased risk for HF and fractures in type 2 diabetes.

Author information

1
Women's College Hospital, Toronto, Ontario, Canada.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center